Department of Veterans Affairs Cooperative Studies Program clinical trial comparing combined warfarin and aspirin with aspirin alone in survivors of acute myocardial infarction: Primary results of the CHAMP study

Circulation

Volumn 105, Issue 5, 2002, Pages 557-563

  Fiore, Louis D ^a   Ezekowitz, Michael D ^a   Brophy, Mary T ^a   Lu, David ^a   Sacco, Joseph ^a   Peduzzi, Peter ^a  

^a VA BOSTON HEALTHCARE SYSTEM   (United States)

Author keywords

Anticoagulants; Aspirin; Myocardial infarction; Trials

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; WARFARIN;

ACUTE HEART INFARCTION; ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CAUSE OF DEATH; CLINICAL TRIAL; CORONARY ARTERY DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; STROKE; SURVIVAL RATE; TREATMENT OUTCOME;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICOAGULANTS; ASPIRIN; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HEMORRHAGE; HOSPITALS, VETERANS; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES; WARFARIN;

EID: 0037022204     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc0502.103329     Document Type: Article

References (16)

1. Collaborative overview of randomized trials of antiplatelet therapy, I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
2. Oral anticoagulant therapy in patients with coronary artery disease: A meta-analysis
3. Efficacy and safety of combined anticoagulant and antiplatelet therapy versus anticoagulant monotherapy after mechanical heart-valve replacement: A meta-analysis
4. Combination Hemotherapy and Mortality Prevention (CHAMP) Study Rationale and Design
5. Antithrombotic agents in coronary artery disease
6. Randomized double-blind trial of fixed low-dose warfarin with aspirin after myocardial infarction
7. Adjusted-dose warfarin versus low- intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomized clinical trial
8. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts
9. Long-term oral anticoagulant therapy in patients with unstable angina or suspected non-Q-wave myocardial infarction: Organization to Assess Strategies for Ischemic Syndromes (OASIS) pilot study results
10. Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users
11. Discrete sequential boundaries for clinical trials
12. Using permutation tests and bootstrap confidence limits to analyze repeated events data from clinical trials
13. Regression models and life tables
14. Mortingale-based residuals and survival models
15. Use of antiplatelet agents and anticoagulants in post- myocardial infarction
16. A clinical study monitoring low-intensity anticoagulant therapy with a standard-sensitivity thromboplastin